Please login to the form below

Not currently logged in

Shire promotes David Colpman to fill global business development role

He replaces Barbara Deptula, who is retiring from the biopharma company

Shire David Colpman global business developmentShire has made two senior promotions, appointing David Colpman to lead its global business development team and elevating Ann Judge to its leadership team.

Colpman will take over from Barbara Deptula, who is retiring after eight years at the helm of the Dublin-based biopharmaceutical company's business development team.

He has been with Shire for over 12 years, leading many of its significant deals, and before that worked at Glaxo Wellcome, Novo Nordisk and Boots Pharmaceuticals in a variety of business development and commercial roles.

Colpman began his industry career at ICI (now AstraZeneca) in formulation and manufacturing and in his new role will report to Shire's chief executive Angus Russell.

Meanwhile Shire has also appointed Ann Judge, currently senior vice president of its global Human Resources team, to the Shire leadership team.

Judge has over 20 years of global HR experience in the pharmaceutical, chemical, and oil and gas industries, having begun her career with Dow Chemical. She joined Shire to lead its global HR team in late 2010, after spending six years with Wyeth Pharmaceuticals (now part of Pfizer).

6th June 2012


Featured jobs

Subscribe to our email news alerts


Add my company

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...